share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

SEC ·  Aug 20 07:13
Summary by Futu AI
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 14,319 shares of the company's Class A Common Stock on August 15, 2024. The shares were sold at a price of $6.69 per share, resulting in a total transaction value of $95,794.11. Following the transaction, Marriott's direct holdings in Recursion Pharmaceuticals amount to 521,138 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 14,319 shares of the company's Class A Common Stock on August 15, 2024. The shares were sold at a price of $6.69 per share, resulting in a total transaction value of $95,794.11. Following the transaction, Marriott's direct holdings in Recursion Pharmaceuticals amount to 521,138 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.